Luckwel Pharmaceuticals Inc logo

LWEL - Luckwel Pharmaceuticals Inc Share Price

$10 0.0  0.0%

Last Trade - 23/11/20

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £n/a
Position in Universe th / 6651
Bullish
Bearish
Unlock LWEL Revenue
Momentum
Relative Strength (%)
1m +154.3%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2014 2015 2016 2017 2018 2019 2020E 2021E CAGR / Avg
0.000 0.000 0.000 0.000 0.000 0.000
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 31 December 2019, LuckwelPharmaceuticals Inc revenues was not reported. Net lossdecreased 40% to $386K. Lower net loss reflects General andadministrative expenses decrease of 40% to $386K (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

LWEL Revenue Unlock LWEL Revenue

Net Income

LWEL Net Income Unlock LWEL Revenue

Normalised EPS

LWEL Normalised EPS Unlock LWEL Revenue

PE Ratio Range

LWEL PE Ratio Range Unlock LWEL Revenue

Dividend Yield Range

LWEL Dividend Yield Range Unlock LWEL Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
LWEL EPS Forecasts Unlock LWEL Revenue
Profile Summary

Luckwel Pharmaceuticals Inc., formerly Luckycom Pharmaceuticals Inc., is a shell company. The Company plans to acquire, develop, manufacture and market pharmaceutical medicines in international tenders managed by World Health Organization-Geneva (WHO). The Company has entered into a license agreement to manufacture, distribute, sell, market and promote the antimalarial medicine Cosunate (artesunate-amodiaquine kit tablets). The Company had not generated any revenue.

Directors
Last Annual March 31st, 2019
Last Interim December 31st, 2019
Incorporated January 2, 2013
Public Since September 9, 2014
No. of Shareholders: n/a
No. of Employees: n/a
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange Pink Sheets on Nasdaq
Shares in Issue 143,376,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
LWEL Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for LWEL
Upcoming Events for LWEL
Frequently Asked Questions for Luckwel Pharmaceuticals Inc
What is the Luckwel Pharmaceuticals Inc share price?

As of 23/11/20, shares in Luckwel Pharmaceuticals Inc are trading at $10, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Luckwel Pharmaceuticals Inc share price performed this year?

Shares in Luckwel Pharmaceuticals Inc are currently trading at $10 and the price has moved by 0.150k% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Luckwel Pharmaceuticals Inc price has moved by 95.1% over the past year.

What are the analyst and broker recommendations for Luckwel Pharmaceuticals Inc?

There are no analysts currently covering Luckwel Pharmaceuticals Inc.

When will Luckwel Pharmaceuticals Inc next release its financial results?

Luckwel Pharmaceuticals Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-12-31
What is the Luckwel Pharmaceuticals Inc dividend yield?

Luckwel Pharmaceuticals Inc does not currently pay a dividend.

Does Luckwel Pharmaceuticals Inc pay a dividend?

Luckwel Pharmaceuticals Inc does not currently pay a dividend.

When does Luckwel Pharmaceuticals Inc next pay dividends?

Luckwel Pharmaceuticals Inc does not currently pay a dividend.

How do I buy Luckwel Pharmaceuticals Inc shares?

To buy shares in Luckwel Pharmaceuticals Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Luckwel Pharmaceuticals Inc?

Shares in Luckwel Pharmaceuticals Inc are currently trading at $10, giving the company a market capitalisation of £n/a.

Where are Luckwel Pharmaceuticals Inc shares listed? Where are Luckwel Pharmaceuticals Inc shares listed?

Here are the trading details for Luckwel Pharmaceuticals Inc:

Country of listing: United States
Exchange: PNK
Ticker Symbol: LWEL
What kind of share is Luckwel Pharmaceuticals Inc?

We were not able to load our ranking data for Luckwel Pharmaceuticals Inc

Is there a Luckwel Pharmaceuticals Inc share price forecast 2021?

We were not able to load any forecast data for Luckwel Pharmaceuticals Inc.

How can I tell whether the Luckwel Pharmaceuticals Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Luckwel Pharmaceuticals Inc. Over the past six months, the relative strength of its shares against the market has been 0.117k%. At the current price of $10, shares in Luckwel Pharmaceuticals Inc are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Luckwel Pharmaceuticals Inc PE Ratio?

We were not able to find PE ratio data for Luckwel Pharmaceuticals Inc.

Who are the key directors of Luckwel Pharmaceuticals Inc?

Luckwel Pharmaceuticals Inc's management team is headed by:

Kingrich Lee - CHM
Who are the major shareholders of Luckwel Pharmaceuticals Inc?

Here are the top five shareholders of Luckwel Pharmaceuticals Inc based on the size of their shareholding:

Lee (Kingrich) Individual Investor
Percentage owned: 56.48% (81.0m shares)
Morgold, Ltd. Corporation
Percentage owned: 17.44% (25.0m shares)
Goldvito Ltd Corporation
Percentage owned: 17.44% (25.0m shares)
Li (Lijian) Individual Investor
Percentage owned: 0.1% (145k shares)
Li (Yongjian) Individual Investor
Percentage owned: 0.06% (85.0k shares)
Similar to LWEL
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.